by Okapit | Dec 18, 2025 | Latest news
Rokote Laboratories Finland Oy is proud to announce that we have received Clinical Trial Authorization (CTA) for our second Phase I clinical trial of the intranasal COVID-19 vaccine. The upcoming study, titled:”A Phase 1a, single-blind, randomized comparative...
by Okapit | Nov 26, 2025 | Latest news
We are pleased to announce the appointment of Terhi Reunama as our new Head of Clinical Trial Operations. Terhi brings nearly 30 years of clinical research experience from both the pharmaceutical industry and CRO organizations. A registered nurse with a Bachelor of...
by Okapit | Jan 21, 2025 | Latest news
Rokote Laboratories Finland Oy is starting the first clinical drug trial with its nasal COVID-19 vaccine. The vaccine has been developed and manufactured in Finland, and the study will be conducted at Kuopio University Hospital starting January 21, 2025. The...
by Okapit | Jul 18, 2024 | Uncategorized
Rokote Laboratories Finland Oy is starting the first clinical drug trial with its nasal COVID-19 vaccine. The vaccine has been developed and manufactured in Finland, and the study will be conducted at Kuopio University Hospital starting January 21, 2025. The...
by Okapit | Dec 9, 2023 | Uncategorized
Finnish vaccine development company Rokote Laboratories Finland Oy is pleased to announce the appointment of its Research and Development Director, Erkko Ylösmäki, as the new CEO, effective January 1, 2024. The company plans to initiate clinical trials for its vaccine...
